Consisting of three theatres and a brand-new poster zone, the programme will explore everything to support the sustainable recovery of respiratory services, from early and accurate diagnosis, service innovation and tackling health inequalities, to long Covid, severe asthma, COPD, Interstitial Lung Disease (ILD), and pulmonary rehabilitation.

The exhibition floor at Respiratory Professional Care presents the UK's largest showcase of products, innovations, and solutions for elevating the provision of respiratory medicine within secondary care, with more than 75 companies on hand to demonstrate how your department can increase efficiencies and improve patient outcomes.

REGISTER FOR YOUR DELEGATE PASS

As the challenges in respiratory medicine continue to evolve, so must Respiratory Professional Care. This year's revitalised approach to the event includes: 

• A more comprehensive focus on secondary care, including full suite of disease areas: COPD, breathlessness, sleep apnoea, asthma, severe asthma, pneumonia, air pollution, occupational lung disease, children's respiratory health, and Interstitial Lung Disease (ILD).
• A new focus on allergies and collaboration with BSACI.
• Increased focus on sleep medicine and sleep apnoea.
• High profile speakers, including:
  • Jonathan Fuld, NHSE national clinical director for respiratory disease
  • Mike Crooks, renowned respiratory physician and senior clinical lecturer

Respiratory Professional Care provides educational content tailored to respiratory professionals, including updates on the latest research, clinical guidelines, and best practices in respiratory care.

Our programme features expert speakers and presenters from various disciplines within respiratory care, including respiratory physicians, nurses, therapists, and researchers, providing valuable insights and perspectives on a range of key topics.

• Severe asthma and new asthma guidelines around pathway and referral to tertiary sites
• Asthma: guidelines on types of inhaler, overuse of SABA, new AIR/MART combinations
• COPD management and use of new biologic treatments
• Ten years sinces NRAD - review of asthma deaths
• Interstitial Lung Disease (ILD) - new therapies available including anti-fibrotics and immunosuppressants
• Tobacco dependency - new BTS guidance, including vaping

• Management of cough - new BTS recommended pathway
• Pneumonia - new report
• Allergies, including triggers for asthma
• Children's respiratory illness, including air pollution and paediatric asthma
• Breathlessness pathway
• Target lung health checks, including cancer screening and early detection of other diseases